Related Experiment Video
Updated: May 5, 2026

Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
Endoscopy as a prognostic marker in inflammatory bowel disease
Marine Camus1, Benjamin Pariente, Xavier Dray
1University Paris Diderot, Sorbonne Paris Cité, Paris, France.
Endoscopic healing in inflammatory bowel disease (IBD) predicts better outcomes. Achieving mucosal healing in ulcerative colitis and Crohn's disease reduces hospitalization, surgery, and relapse risks.
Area of Science:
- Gastroenterology
- Internal Medicine
Background:
- Historically, endoscopic lesion assessment was deemed less critical for inflammatory bowel disease (IBD) management.
- Recent therapeutic advances have increased the likelihood of achieving mucosal healing (MH).
Purpose of the Study:
- To review evidence supporting the prognostic value of endoscopy in inflammatory bowel disease.
- To highlight the benefits of achieving mucosal healing in ulcerative colitis and Crohn's disease.
Main Methods:
- Review of existing literature and studies on endoscopic findings in IBD.
- Analysis of prognostic implications of mucosal healing versus persistent inflammation.
Main Results:
- Mucosal healing (MH) in ulcerative colitis and Crohn's disease is associated with a lower risk of hospitalization and surgery.
- Patients achieving MH have a reduced risk of relapse after treatment cessation.
- Controlled inflammatory lesions appear to correlate with a lower long-term cancer risk.
Conclusions:
- Endoscopic assessment and achieving mucosal healing are crucial for predicting prognosis in IBD.
- MH signifies a favorable outcome, impacting hospitalization, surgery, relapse, and potentially cancer risk.
- Further research is needed to determine optimal treatments when MH is not achieved.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

